/BioProcess International: Cell & Gene Therapy Manufacturing & Commercialization US

BioProcess International: Cell & Gene Therapy Manufacturing & Commercialization US

23 - 26 September 2024 | Boston, USA

The cell and gene therapy event for ground-breaking manufacturing, commercialization and supply chain strategies

Imec

Peter Peumans, CTO Health (imec), will be participating in the following panel discussion within the Cell Therapy Manufacturing stream.

Building a Collaborative Distributed Manufacturing Ecosystem

Tuesday, 24 September 2024 (14:00 - 14:30)

  • Reducing wait times and logistical magnitude to reduce overhead costs.
  • Increasing accessibility, distributing to multiple locations closer to patient populations and remove transportation cost barriers.
  • How QC release testing and material kitting and management will be handled for POC manufacturing in this ecosystem.
  • Establishing harmonized regulatory standards across different regions.
  • Implementing robust oversight mechanisms to ensure compliance with regulatory requirements and maintain product in a distributed manufacturing model.
  • EMA vs FDA approach.

About

BioProcess International is a major annual event in the biopharmaceutical industry held in Boston. It serves as a key gathering for professionals in bioprocessing, manufacturing, and drug development, offering a platform to explore the latest innovations in biologics, cell and gene therapy, and biomanufacturing technologies. The event features a comprehensive agenda of keynote presentations, panel discussions, and workshops, covering topics such as upstream and downstream processing, analytical development, and quality control.

Learn more